Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymectomy for myasthenia gravis

J D Urschel1, R P Grewal

  • 1Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY 14263-0001, USA.

Postgraduate Medical Journal
|June 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern.

Acta neuropathologica·2020
Same author

Genetic basis of resistance to zonate leaf spot disease in forage sorghum.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Phenotype-genotype analysis of dystrophinopathy caused by duplication mutation in Dystrophin gene in an African patient.

African health sciences·2012
Same author

The G1138A mutation rate in the fibroblast growth factor receptor 3 (FGFR3) gene is increased in cells carrying the t (4; 14) translocation.

Genetics and molecular research : GMR·2009
Same author

The intron 4c allele of the NOS3 gene is associated with ischemic stroke in African Americans.

BMC medical genetics·2007
Same author

Axonal neuropathy caused by epothilone B.

Neurology India·2007

Thymectomy is a valuable treatment for generalized myasthenia gravis, though surgical approaches vary. Complete thymus removal is crucial, but excising surrounding tissue remains debated. Multidisciplinary care minimizes risks.

Area of Science:

  • Neurology
  • Surgical Oncology

Background:

  • The thymus's role in myasthenia gravis (MG) pathophysiology and thymectomy's therapeutic mechanisms are not fully elucidated.
  • Despite incomplete understanding, thymectomy is a recognized treatment for select generalized MG patients.

Purpose of the Study:

  • To review the current understanding of thymectomy in managing generalized myasthenia gravis.
  • To discuss the controversies and considerations in surgical approaches to thymectomy.

Main Methods:

  • Review of existing literature on thymectomy for myasthenia gravis.
  • Analysis of different surgical techniques and their implications.

Main Results:

  • Total thymus gland removal is essential for effective treatment.

Related Experiment Videos

  • Surgical approaches vary, with debate on the necessity of excising extrathymic tissue.
  • Minimizing operative morbidity requires a multidisciplinary approach.

    • Conclusions:

    • Thymectomy is a key therapeutic option for generalized myasthenia gravis.
    • Surgical strategy, including extent of tissue removal, requires careful consideration.
    • Peri-operative care involving neurology, surgery, and anesthesia is vital for optimal outcomes.